Shopping Cart
- Remove All
Your shopping cart is currently empty
EGFR-IN-60 is an effective, orally active, safe antitumor agent. EGFR-IN-60 significantly inhibits EGFRWT (IC50: 83 nM), EGFRT790M (IC50: 26 nM), EGFRL858R (IC50: 53 nM) and JAK3 (IC50: 69 nM). IN-60 inhibited H1975 cells carrying the EGFRT790M mutation (IC50: 1.32 μM) and A431 cells overexpressing EGFRWT (IC50: 4.96 μM). EGFR-IN-60 increased the Bax/Bcl-2 ratio, which induced apoptosis induction and cell death.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,140 | 6-8 weeks | |
| 50 mg | $2,785 | 6-8 weeks | |
| 100 mg | $3,520 | 6-8 weeks |
| Description | EGFR-IN-60 is an effective, orally active, safe antitumor agent. EGFR-IN-60 significantly inhibits EGFRWT (IC50: 83 nM), EGFRT790M (IC50: 26 nM), EGFRL858R (IC50: 53 nM) and JAK3 (IC50: 69 nM). IN-60 inhibited H1975 cells carrying the EGFRT790M mutation (IC50: 1.32 μM) and A431 cells overexpressing EGFRWT (IC50: 4.96 μM). EGFR-IN-60 increased the Bax/Bcl-2 ratio, which induced apoptosis induction and cell death. |
| Targets&IC50 | EGFR:0.083 μM, EGFR T790M:0.026 μM, JAK3:0.069 μM, EGFR L858R:0.053 μM |
| Molecular Weight | 535.47 |
| Formula | C28H28Cl2N6O |
| Cas No. | 2699877-43-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.